1/ Afternoon with a Grady elder: Me: "I heard you had a lot of visitors today. I hate I missed them." Her: "Yeah. It was mostly good." Me: "Mostly?" Her: "Mmmm hmm." *silence while watching TV* Her: *sighing* "My granddaughter got upset with me." Me: "Oh man. Why?"

#HematologyTweetstory 34: Vitamin K. This tale includes 2 larger-than-life characters, self experimentation, & bloody cows. Also, yours truly was once *so* dedicated to hematology history that he drove to rural Wisconsin to search local property records related to this story.😉/1

1/ PM rounds at Grady Him: "You alright, doc?" Me: "Me?" Him: "Yeah you. You seem outta sorts." *silence* Me: *smiles* "I'm in sorts I promise. Now tell me--you alright?" Him: "Me? Feeling a little better." Me: "How's your wind?" Him: "Waaay better." Me: "Yay."

So happy to be part of the return to normal after getting my Covid vaccine this morning. Join me when you can!

Hanging out with the oncologist

So excited and honored!

Today, the FDA approved dapagliflozin to reduce the risk of kidney function decline, kidney failure, CV death and hospitalization for HF in adults with CKD who are at risk of disease progression. FDA Approves Treatment for Chronic Kidney Disease fda.gov/news-events/pr…

Dr. Savannah Duckworth is a shining star in our department! 🌟

Dear NBC Olympics & Paralympics and @cnbc When someone hits a walkoff in extra innings…WE NEED TO SEE THE REPLAY. Clutch USA Softball win and we go right to studio where they don’t even mention game. 🤦🏼‍♀️🤬

COVID +, unvaccinated patient—presented with high risk submassive PE related to COVID. Great, quick action by The University of Mississippi Medical Center evolving #PERT . We performed pulmonary embolectomy today with improving status. Please #MaskUp #VaxUp MS!! University Heart at UMMC Gabriel A Hernandez MD FACC FSCAI Michael Brewer @jgeoharv

Parasternal short axis mid papillary view of jalapeño

I mean it’s an honest question

Excited to announce I matched UW–Madison for Hematology/Oncology fellowship! Can’t wait to join University of Wisconsin Department of Medicine next year.

The first randomized trial of CAR-T in multiple myeloma. nejm.org/doi/full/10.10… Ide-cel versus a choice of five regimens for relapsed multiple myeloma! Lots to learn and process from this trial- so let us get started with this deep-dive 🧵 #mmsm

🚨🔥OncoAlert Hot off the press. U.S. FDA granted #accelerated approval to #Tarlatamab-dlle (bispecific T-cell engager targeting #DLL3 and #CD3) for #ExtensiveStage #SmallCell #LungCancer with disease progression after platinum-based #Chemotherapy. 👇🏼 fda.gov/drugs/resource…

Excited to have seen this presented SABCS this morning! Great conference so far.

Annual gathering of the Big Ten CRC #breastcancer research team at #SABCS24. Oana Danciu Peyton Reves Darian Louthan Malinda T West Kari Wisinski Anne Schott, MD Coral Omene, MD, PhD Mark Burkard Marina Sharifi Mridula George

Osimertinib BEATEN!! MARIPOSA (Ami + Lazer) shows significant OS (HR 0.75, p<0.005, 3yr 60% vs 51%) and landmark 3-yr icPFS improvement (36% vs 18%)—first combo to show OS superiority over SoC, extending OS beyond 3 years in 1L EGFRm NSCLC. #ESMOAmbassadors #ELCC25 ESMO - Eur. Oncology

Small Cell Lung Cancer A Reviem JAMA jamanetwork.com/journals/jama/…